Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical Cancer

Yonsei Medical Journal

Volumn 49, Issue 6, 2008, Pages 993-1003

  Lim, Myong Cheol ^a,b   Kim, Joo Young ^a   Kim, Tae Hyun ^a   Park, Sohee ^a   Kong, Sun Young ^a   Yoon, Jung Hyun ^a   Kang, Sokbom ^a   Seo, Sang Soo ^a   Park, Sang Yoon ^a  

^a National Cancer Center   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Anemia; Blood transfusion; Cervical cancer; Metastasis; Radiotherapy

Indexed keywords

CISPLATIN; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEUM METASTASIS; PROGNOSIS; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD TRANSFUSION; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 58149457785     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.6.993     Document Type: Article

References (31)

1. Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000;57:13-9.
2. Marchal C, Rangeard L, Brunaud C. [Anemia impact on treatments of cervical carcinomas]. Cancer Radiother 2005;9:87-95.
3. Vaupel P, Thews O, Mayer A, Höckel S, Höckel M. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level? Strahlenther Onkol 2002;178: 727-31.
4. Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 2005;63:25-36.
5. Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC, et al. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:67-71.
6. Dunst J. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing? Strahlenther Onkol 2004;180:671-81.
7. Obermair A, Cheuk R, Horwood K, Neudorfer M, Janda M, Giannis G, et al. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival. Int J Gynecol Cancer 2003;13:633-9.
8. Lavey RS, Liu PY, Greer BE, Robinson WR 3rd, Chang PC, Wynn RB, et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. Gynecol Oncol 2004;95:145-51.
9. Wun T, Law L, Harvey D, Sieracki B, Scudder SA, Ryu JK. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 2003;98:1514-20.
10. Günter P. Practice guidelines for blood component therapy. Anesthesiology 1996;85:1219-20.
11. Birgegård G, Bokemeyer C. New guidelines on anaemia management in patients with cancer: How do these affect clinical practice? Oncology 2005;69 Suppl 2:17-21.
12. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001;113:24-31.
13. Okuno K, Ozaki M, Shigeoka H, Nakajima I, Nakamura K, Hirohata T, et al. Effect of packed red cell and whole blood transfusion on liver-associated immune function. Am J Surg 1994;168:340-4.
14. Clarke PJ, Burton RC, Wood KJ. Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour. Int J Cancer 1993;55:996-1002.
15. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998;74 Suppl 2:315-9.
16. Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically? Hematology 2005; 10 Suppl 1:208-14.
17. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303-9.
18. Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc 2003;78:1274-80.
19. Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol 2002;42:65-78.
20. Clifton KH, Jirtle R. Mammary carcinoma cell population growth in preirradiated and unirradiated transplant sites. Viable tumor growth, vascularity, and the tumor-bed effect. Radiology 1975;117:459-65.
21. Zips D, Eicheler W, Brüchner K, Jackisch T, Geyer P, Petersen C, et al. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Int J Radiat Biol 2001;77:1185-93.
22. Petersen C, Eicheler W, Baisch H, Zips D, Baumann M. Impact of preirradiation of the tumour bed on cell production rate and cell loss of human FaDu squamous cell carcinoma growing in nude mice. Int J Radiat Biol 1999;75:1293-7.
23. Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. The controversial abscopal effect. Cancer Treat Rev 2005;31:159-72.
24. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004;58:862-70.
25. Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, et al. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys 2002;54:1345-55.
26. Quigley RL. The effect of leukocytes on adhesion molecules. An explanation of blood transfusion enhancement of tumor growth. Arch Surg 1996;131:438-41.
27. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-81.
28. Yang HJ, Liu VW, Tsang PC, Yip AM, Tam KF, Wong LC, et al. Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer 2004;14:903-10.
29. Nagai Y, Toma T, Moromizato H, Maehama T, Asato T, Kariya K, et al. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy. Am J Obstet Gynecol 2004;191:1907-13.
30. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003;54:908-14.
31. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004;109:2755-60.